Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Completed · Phase 4
Conditions studied: Migraine
In brief
The purpose of the study is to evaluate the treatment satisfaction of subjects using Sumavel DosePro to treat their moderate to severe migraines.
Key facts
- Study ID
- NCT01016834
- Run by
- Zogenix, Inc.
- People needed
- 246
- Starts
- 2009-11-30
- Expected to finish
- 2010-04-30
- Last updated by the study team
- 2026-06-08
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- History of 2 to 6 migraine headaches per month
- Migraines should have been present for at least 1 year with age at onset of migraine less than 50 years
- History of 24 hours of freedom between migraine attacks
- Current users of triptan medications
- Able to distinguish interval or other non-migrainous headaches from typical migraine
- General good health
You may not qualify if…
- History or symptoms, or signs of ischemic cardiac, cerebrovascular, or peripheral vascular syndromes
- Significant underlying cardiovascular diseases including uncontrolled hypertension
- Hemiplegic or basilar migraine
- History or diagnosis of severe hepatic or renal impairment
- History of epilepsy or seizure or other serious neurologic condition
- History of allergy, anaphylaxis, or hypersensitivity to sumatriptan or any of its components or similar drugs including sulphonamides
- History of scleroderma (systemic sclerosis)
- Pregnant or breastfeeding
- Use of contraindicated prescription medications, monoamine oxidase inhibitors (MAO-A), selective serotonin reuptake inhibitors, or lithium agents
Where it is running
- University of Alabama Hospital, Dept. of Neurology — Birmingham, Alabama, United States
- Arizona Research Center — Phoenix, Arizona, United States
- C. Phillip O'Carroll, MD, Inc — Newport Beach, California, United States
- California Medical Clinic for Headache — Santa Monica, California, United States
- Alpine Clinical Research — Boulder, Colorado, United States
- University Clinical Research Inc. — Pembroke Pines, Florida, United States
- Comprehensive Neuroscience Inc — St. Petersburg, Florida, United States
- Comprehensive Neurosciences Inc — Atlanta, Georgia, United States
- Neurology Specialists of Decatur — Decatur, Georgia, United States
- Diamond Headache Clinic — Chicago, Illinois, United States
- Michigan Head, Pain, & Neurological Institute — Ann Arbor, Michigan, United States
- Clinvest/A Division of Banyan Group, Inc — Springfield, Missouri, United States
- Mercy Health Research — St Louis, Missouri, United States
- Meridian Clinical Research — Omaha, Nebraska, United States
- Regional Clinical Research Inc — Endwell, New York, United States
- Headache Wellness Center — Greensboro, North Carolina, United States
- Cleveland Clinic: Neurological Center for Pain — Cleveland, Ohio, United States
- Jefferson Headache Center — Philadelphia, Pennsylvania, United States
- Neurological Medicine — Clarksville, Tennessee, United States
- Nashville Neuroscience Group — Nashville, Tennessee, United States
- Swedish Pain and Headache Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.